Beneficial effect of interferon-beta treatment in patients with multiple sclerosis is associated with transient increase in serum IL-6 level in response to interferon-beta injection.
Nakatsuji Y, Nakano M, Moriya M, Kishigami H, Tatsumi C, Tada S, Sadahiro S, Naka T, Mitani K, Funauchi M, Azuma T, Watanabe S, Kinoshita M, Kajiyama K, Yuasa Y, Kaido M, Takahashi MP, Naba I, Hazama T, Sakoda S; Osaka Neurological Research Consortium.
Nakatsuji Y, et al. Among authors: watanabe s.
Cytokine. 2006 Oct;36(1-2):69-74. doi: 10.1016/j.cyto.2006.10.013. Epub 2006 Dec 11.
Cytokine. 2006.
PMID: 17161613
Clinical Trial.